Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for cancer-related fatigue in advanced cancer patients (Dex8mgPII)
jRCTs031180068Phase 2Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Oct 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dexamethasone in cancer-related fatigue (CRF), malignant solid tumor and hematopoietic malignancies, sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Change of FACIT-Fatigue subscale score at day 8. Started Oct 2017; status: completed.
02
Drugs
dexamethasone
03
Conditions
cancer-related fatigue (CRF)malignant solid tumorhematopoietic malignancies
Beyond the preview
Go deeper on jRCTs031180068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180068.